World’s First Clinical Trial for anti-Abeta Vaccine Targeting Alzheimer’s Disease-like Characteristics in People with Down Syndrome

Categories: Blog, Clinical Trials, Ds / Alzheimer's Connection, Ds Research, News
PRESS RELEASE – Issued by AC Immune Studies AC Immune’s ACI-24, the first anti-amyloid vaccine for treatment of Alzheimer’s disease-like characteristics in people with Down syndrome Clinical Study is done in collaboration with University of California San Diego US NIH provides significant funding with an additional grant from the LuMind Research Down Syndrome Foundation Alzheimer’s …

Read More

Q&A With Dr. William Mobley

Categories: Blog, Ds Research, News, Why Support Research?

Did you attend our webinar in January and ask a question that wasn’t answered? Dr. William Mobley has the answers! Dr. Mobley from the University of California, San Diego’s Down Syndrome Center for Research and Treatment and Dr. Jamie Edgin from the University of Arizona’s Down Syndrome Research Group spoke at our webinar on January 29, …

Read More

UCSD Study Unraveling the Complexities between Down Syndrome and Alzheimer’s Disease

Categories: Blog, Ds / Alzheimer's Connection

Our friends at University of California, San Diego are helping to unravel the complexities of Down syndrome and Alzheimer’s disease. A news report from WFMZ in San Diego refers to a three-year pilot project involving a relatively small set of individuals with Down syndrome, like the impressive Jonathan Shirley. Dr. Mike Rafii, the principal investigator on …

Read More

LuMind Foundation 2013-2014 Grant Awards Exceed $1M

Categories: News

LuMind Foundation has provided over $9.6 million to advance Down syndrome cognition research.  Recipients of this year’s funding include researchers at : Johns Hopkins Medicine University of California, San Diego University of Arizona Stanford University, and VA Palo Alto Health Care System. Read more details about the awards in the research section of our website.